Fig. 5From: Her2-Functionalized Gold-Nanoshelled Magnetic Hybrid Nanoparticles: a Theranostic Agent for Dual-Modal Imaging and Photothermal Therapy of Breast CancerCell viabilities of a MDA-MB-231 and b SKBR3 cells at different dosages of Her2-GPH NPs (0, 10, 20, 50, 100, 200 μg/mL) for 12 h and 24 h (data expressed as mean ± SD, n = 4)Back to article page